TY - JOUR
T1 - Calibrating for Comorbidity
T2 - Clinical Decision-Making in Youth Depression and Anxiety
AU - Chu, Brian C.
AU - Merson, Rachel A.
AU - Zandberg, Laurie J.
AU - Areizaga, Margaret
N1 - Funding Information:
This research was supported in part by a grant from the Klingenstein Third Generation Foundation. The authors wish to acknowledge the parents and youth who participated in the research described herein.
PY - 2012/2
Y1 - 2012/2
N2 - Comorbidity in clinical youth populations is more the rule than the exception, yet few established guidelines exist to help practicing clinicians manage complex diagnostic profiles. The current paper reviews efforts within the treatment development literature to handle comorbidity in depressed and anxious children and adolescents, including single-target, modular-based, and transdiagnostic interventions. Two case studies are presented to describe how comorbid anxiety and depression are managed within two different evidence-based single-target interventions. A third case is presented to introduce a novel individual behavioral activation therapy (IBAT) designed to address co-occurring depression and anxiety by targeting a single maintaining mechanism (avoidance) that underlies both disorders. Implications for clinical decision-making (assessing complex clinical profiles in practice, prioritizing treatment goals, selecting interventions from a broad evidence base) are discussed.
AB - Comorbidity in clinical youth populations is more the rule than the exception, yet few established guidelines exist to help practicing clinicians manage complex diagnostic profiles. The current paper reviews efforts within the treatment development literature to handle comorbidity in depressed and anxious children and adolescents, including single-target, modular-based, and transdiagnostic interventions. Two case studies are presented to describe how comorbid anxiety and depression are managed within two different evidence-based single-target interventions. A third case is presented to introduce a novel individual behavioral activation therapy (IBAT) designed to address co-occurring depression and anxiety by targeting a single maintaining mechanism (avoidance) that underlies both disorders. Implications for clinical decision-making (assessing complex clinical profiles in practice, prioritizing treatment goals, selecting interventions from a broad evidence base) are discussed.
UR - http://www.scopus.com/inward/record.url?scp=84856059123&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84856059123&partnerID=8YFLogxK
U2 - 10.1016/j.cbpra.2010.10.005
DO - 10.1016/j.cbpra.2010.10.005
M3 - Article
AN - SCOPUS:84856059123
SN - 1077-7229
VL - 19
SP - 5
EP - 16
JO - Cognitive and Behavioral Practice
JF - Cognitive and Behavioral Practice
IS - 1
ER -